Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0P3PB
|
|||
Former ID |
DIB007377
|
|||
Drug Name |
RX-10045
|
|||
Synonyms |
Resolvin (inflammation), Resolvyx Pharmaceuticals
Click to Show/Hide
|
|||
Indication | Ocular disease [ICD-11: N.A.] | Phase 2 | [1] | |
Company |
Resolvyx Pharmaceuticals Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H24O4
|
|||
Canonical SMILES |
CC(C)OC(=O)CCCC(C#CC=CC=CC(CC#C)O)O
|
|||
InChI |
1S/C18H24O4/c1-4-10-16(19)11-7-5-6-8-12-17(20)13-9-14-18(21)22-15(2)3/h1,5-7,11,15-17,19-20H,9-10,13-14H2,2-3H3/b6-5+,11-7+/t16-,17-/m1/s1
|
|||
InChIKey |
ZVOCIIHCJJEFRQ-BHXBHYJPSA-N
|
|||
CAS Number |
CAS 1251537-11-7
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01675570) A Study of RX-10045 in the Treatment of Dry Eye Disease. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.